BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories metabolic, neurology news

Forest's Forest Pharmaceutical Inc. subsidiary agreed to pay more than $313 million to settle criminal and civil charges that it sold an unapproved hypothyroidism drug, improperly promoted antidepressants and obstructed an FDA investigation.

Forest will plead guilty to distributing an unapproved drug, Levothroid levothyroxine, from 2001-03 after FDA established...

Read the full 226 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >